|
Neuropsychological Evaluation of Psychiatric and Neurological Patients Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Neuropsychological Evaluation of Psychiatric and Neurological Patients conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Neuropsychological Evaluation of Psychiatric and Neurological Patients Clinical research trials and Neuropsychological Evaluation of Psychiatric and Neurological Patients medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Neuropsychological Evaluation of Psychiatric and Neurological Patients. Neuropsychological Evaluation of Psychiatric and Neurological Patients Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Neuropsychological Evaluation of Psychiatric and Neurological Patients clinical trial. Subjects often receive the most expert healthcare possible for their Neuropsychological Evaluation of Psychiatric and Neurological Patients condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > Neuropsychological Evaluation of Psychiatric and Neurological Patients  Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
For Condition: Anxiety Disorder,Head Injury,Mood Disorder,Schizophrenia,Seizures
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: This study will allow researchers to use various types of tests to evaluate cognitive and sensory functions. These tests, referred to as "batteries" will evaluate attention, executive functions, general intellectual functioning, language, memory, motor functions, orientation, personality, selected sensory and perceptual functions, vigilance (alertness), and visual-spatial functions. Children and adult patient will receive different test batteries. The goals of this research study are to; 1. Create descriptions based on the performance of each patient on the test batteries. Then use this information to relate patient behavior to their neurophysiological, neuroradiological, and biochemical descriptions. 2. Define subgroups of patients based on their neurobehavior in order to decrease the variability of psychiatric diagnoses, treatments, and prognoses.
Details: Neuropsychological tests are used to provide an assessment of cognitive functions in patients with idiopathic generralized epileptic (IGE) disorders and their first-degree relatives. The battery comprises tests designed to tap attention, memory, selected sensory and perceptual functions, vigilance, and visual-spatial functions. Modified batteries have been developed for the assessment of children ages 5-8, and children ages 8-16. The data provided by these batteries are compared with genetic profiles of the same participants that have been ascertained from blood samples analyzed by colleagues at the Mount Sinai School of Medicine/Columbia University in New York City.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients. Normal volunteers. EXCLUSION CRITERIA: Subjects over 95 years of age. Subjects with a history of alcohol or drug abuse, psychopathology, or central nervous system pathology, other than that which defines group membership, may be excluded.
Total Enrollment: 4300
Location and Contact Information:
National Institute of Mental Health (NIMH) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 830176; 83-M-0176
Study Start Date: October 18, 1983
Record last reviewed: January 24, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001192
Other Anxiety Disorder Studies:
1. Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
2. Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients with Anxiety
3. Neuropsychological Evaluation of Psychiatric and Neurological Patients
4. Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation
5. Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
Related Studies:
Other Anxiety Disorder Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
|
|
|
|
|
|
|
|
